Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cryptophycin anticancer drugs revisited.

Jürgen Rohr1

  • 1Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, 725 Rose Street, Lexington, Kentucky 40536-0082, USA. jrohr2@email.uky.edu

ACS Chemical Biology
|January 24, 2007
PubMed
Summary

Researchers uncovered the building blocks and genetic code for producing cryptophycin anticancer compounds from cyanobacteria. This discovery enables the synthesis of these promising natural products for potential cancer treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bridging Tumor Growth Dynamics and Survival in Preclinical Oncology Drug Development - A Translational Tumor Growth Inhibition and Time to Event (TGI-TTE) Modeling Framework.

Research square·2026
Same author

Physiologically Based Pharmacokinetic Modeling to Predict Human Pharmacokinetics of a Novel Mithramycin Analog for Ewing Sarcoma.

Research square·2026
Same author

Nonlinear Mixed-Effects Modeling to Characterize the Pharmacokinetics of a Novel Mithramycin Analogue for Ewing Sarcoma in Mice.

Research square·2026
Same author

Preclinical Pharmacokinetic Evaluation of Mithramycin and Mithramycin SA Tryptophan-Conjugated Analog.

Pharmaceutics·2025
Same author

The Position of Indole Methylation Controls the Structure, DNA Binding, and Cellular Functions of Mithramycin SA-Trp Analogues.

Chembiochem : a European journal of chemical biology·2025
Same author

Highly diverse endophytic fungi from Serra do Amolar-Pantanal (Brazil) producing bioactive secondary metabolites against phytopathogens.

Frontiers in microbiology·2025

Area of Science:

  • Biochemistry
  • Natural Product Synthesis
  • Pharmacology

Background:

  • Cryptophycins are potent anticancer agents derived from lichen cyanobacterial symbionts.
  • Their complex structures and limited natural abundance hinder clinical development.
  • Understanding the biosynthetic pathway is crucial for enabling production.

Discussion:

  • This study elucidates the key enzymes, genetic basis, and substrate flexibility within the cryptophycin biosynthetic pathway.
  • Identified enzymes demonstrate a broad tolerance for various substrates, suggesting potential for analog generation.
  • The findings provide a comprehensive map of the cryptophycin assembly line.

Key Insights:

  • The biosynthetic pathway's genetic code and enzymatic machinery have been revealed.
  • Enzymes exhibit broad substrate tolerance, facilitating the production of diverse cryptophycin analogs.
  • This research establishes the foundation for producing these valuable anticancer compounds.

Outlook:

  • Enables chemoenzymatic production and precursor-directed biosynthesis of cryptophycins.
  • Facilitates the re-evaluation of cryptophycin candidates in clinical trials.
  • Opens avenues for developing novel anticancer therapeutics based on cryptophycin scaffolds.

Related Experiment Videos